Balixafortide (TFA)
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-P1682A-5MG | 5 mg | 229,00 | Add | |
| HY-P1682A-10MG | 10 mg | 359,00 | Add | |
| HY-P1682A-25MG | 25 mg | 799,00 | Add | |
| HY-P1682A-50MG | 50 mg | 1'343,00 | Add |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
Balixafortide TFA (POL6326 TFA) is a potent, selective, well-tolerated peptidic CXCR4 antagonist with an IC50 < 10 nM. Balixafortide TFA shows 1000-fold selective for CXCR4 than a large panel of receptors including CXCR7. Balixafortide TFA blocks β-arrestin recruitment and calcium flux with IC50s < 10 nM. Balixafortide TFA is also a potent hematopoietic stem and progenitor cell (HSPC) mobilizing agent. Anti-cancer effects[1][2].
| Category | Peptide |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Cancer, GPCR/G Protein,Immunology/Inflammation |
| Format | Solubility: DMSO : 100 mg/mL (ultrasonic);H2O : 100 mg/mL (ultrasonic) |
| Grade | Clinical information: Phase 3 |
| Purity | 99.78% |
| Molecular Formula | C86H119F3N24O23S2 |
| Molecular Weight | 1978.16 |
| Storage Conditions | -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Blue Ice |
| Material Safety Data Sheet | Download PDF |
